[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-DFTX":3,"homepage-market-summary":31,"stock-news-DFTX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"DFTX","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Definium Therapeutics, Inc. Common Shares","Nasdaq",null,"MEDICINAL CHEMICALS & BOTANICAL PRODUCTS","Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.","106","New York, NY",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},37.4,37.7,38.14,36.86,37.6,-0.2,-0.53,1596481.728366,19806,37.3236,49.7,10.465,2186962.087393016,68.7,2480,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},20,[176,182,188,194,200,206,212,218,223,228,233,237,242,247,252,257,262,267,273,279],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Definium Therapeutics (DFTX) Stock Climbed, So What Is Behind The Fresh Attention? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Mon, 28 Sep 2026 23:26:38 GMT","Definium Therapeutics (DFTX) Stock Climbed, So What Is Behind The Fresh Attention? Simply Wall Street","Simply Wall Street",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"DFTX Stock On Track For Worst Day In 9 Months As Investors Brace For Anxiety Trial Data - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxPLXVUdWdUcXNrQWw3LXVVdXpXcEIySFEyMk1IR19SZ05sMC0xVlhPSWpmVnFNYmlQbklwVmtBbmFUYUcxTDZuMXVjdS1BSnBVT0dTLXp1SnZkVmMyQk9uUlVISE9oOEhVTC1jdFh2djc3SVJSMjhtVUNEem5lUC1JeUN5TVpkemtRcXYyQkxabFhZODkxTVFJRlp2OGNoOC1ueTMtRk4xUlhtOUJEZWhpUG9MSENmR043Z0FOcG9kRV9SYlVmZENheTJiWlJjVDJUUmZaVTdTSmlMWFloczROekg3RFZlUQ?oc=5","Fri, 02 Oct 2026 17:29:23 GMT","DFTX Stock On Track For Worst Day In 9 Months As Investors Brace For Anxiety Trial Data Stocktwits","Stocktwits",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"15 new hires get the right to buy Definium shares in stages over four years - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxQVGZEVFVBM0FOX1FGQ1BfSmVGRUV4T08wai1NRldXWXVHa2ZIbWFQcHRVQXZERTVHYWQwdlp6LUNTOWNOSnZVb2ZSTWNOLUQwSTBvbVUxYnpaenhqcVVzemt4TWJPNkhiekE2UnlERHY2SW1VNnJfVHNLNkxXbFU4ZGtDcEw3eXhlNzYwMUlOR1NCMHNObU9tVWEwb2xFMlNFNXg0OWZYd1pZRDBpRnFj?oc=5","Mon, 28 Sep 2026 20:01:00 GMT","15 new hires get the right to buy Definium shares in stages over four years Stock Titan","Stock Titan",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Definium Therapeutics Insider Sold Shares Worth $1,153,784, According to a Recent SEC Filing - finance.yahoo.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxQWkZ0VmFRdnZIajhWOWQ4RXB1S1dRQ0FTN1VpT2w0WkRYc2tmRHBuelN1TDN3U1RBLWVsZER4dGtkcXZlamNHOGNNdUhZWlp2NzRHeFl2UUhVU2ZzVHF3YkxETzNuYnFNYnFTdVBkbTYxQlZHbEJEV2cwQWVvT1BiY2JBeW1rbm82UlVNbFJGU1JmU1JIM2ZvbDU1c0VRZFJGNGV2aENWUkNHdw?oc=5","Wed, 30 Sep 2026 08:02:43 GMT","Definium Therapeutics Insider Sold Shares Worth $1,153,784, According to a Recent SEC Filing finance.yahoo.com","finance.yahoo.com",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"Definium Therapeutics Inc (DFTX-Q) Stock Price and News - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMib0FVX3lxTE5VZFNFVWJ5MW02TGE0R2ZvblI1Snc5ZmxZYUJEMHJiN25ydFQxT3o1SEFqT2dMMGJmRWpoTUI5LXU0a096TVNlYmdHUW9wSmFUT2NFNlVMUVFXY1VQX21uY2Z3azliQWxZRklWOE1ERQ?oc=5","Thu, 01 Oct 2026 21:46:34 GMT","Definium Therapeutics Inc (DFTX-Q) Stock Price and News The Globe and Mail","The Globe and Mail",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Discipline and Rules-Based Execution in DFTX Response - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizgFBVV95cUxOc081bURBaEVXaTREa19oZ2JmNFdfcDVlZGlJb3VfWEJyX1kzaTI5Q0ptcFY2NkRoUVN1YXNtOHlqWFc1cGZhZ0N1V2FzNTc0d1NzNHdwaTU2ZVdrNmtHb09BZ3N1RWFDWnJTaFIwa1UyR0V3eG40bzNmYjlnMDlCbjhYWDdDVGF5dXo2aWE3SzVtY05pMWFJeVR2Z05hZTl0X0w0anVhUXVGZGZBUXN5TWQzLUN3WS14WjZjaHd6ZXdlLWprb19MRWFEUFAydw?oc=5","Sun, 27 Sep 2026 15:02:02 GMT","Discipline and Rules-Based Execution in DFTX Response Stock Traders Daily","Stock Traders Daily",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"Definium Therapeutics CMO Daniel Karlin sells $396,894 in stock - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxQNV9FejB0YmU5U25UVUsySWhBUUtZN3hkOEYwNlBrQnh4WDVtbThRbEpTRElncDZvcGxaWTh2UzJVWmNLSGVCZ0VTSWNoUE4zV3daUVphdEdUdk5CT3lMdDNDZjFxMmNXVG9yczRWWDBTZHBSZUVtei0zOHB0VUdXV2lIbk1QSS1WWUt6OVdLYTJBV0dIRFF2VVhvU0RHNkl3T1BSUnN5WTZRYmxvZGk5WTVvUS03dEFkUUFOd2ItVURJWkZR?oc=5","Wed, 30 Sep 2026 02:08:05 GMT","Definium Therapeutics CMO Daniel Karlin sells $396,894 in stock Investing.com","Investing.com",{"title":219,"link":220,"pubDate":221,"description":222,"source":187},"DFTX Stock Rallies As Psychedelic Drug Delivers Positive Anxiety Trial Results — Retail Says DT120 Could ‘Disrupt The Market’ - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAJBVV95cUxOay00RC1DbXpDVk5HX2JpSVVmNEVpalhoRmwzY19ZSFMxcHJ3amd1eHo3WXBwdnNlQ0l0WGFLOXRYYThSbnJQb2ZHR2lJV1B2ZGxxekZuWkJkZE5JWkhldmFmTkRnSHRLejM4eGpBeU5OcHdxVC1OSXVpTDN4MF9QYUJvRlBpWVVJN19lc1V6RFdBYkp6THdSd0t3TW5mdEk4bks4aURNT181NVduQkdLZzJOQ21mSUJQdm1lZmx4N2I5R2ZXOXVDaVd6bnJTWTlEUkxETHNQaVNYcDNSNFdaZGllajFwRmVaR2ZFaUR1YTZjNUY1YzR4bjRKM0VlbzJQTG5WYmQxNTlEVk1pblZDbGRqWUY?oc=5","Sun, 04 Oct 2026 04:53:43 GMT","DFTX Stock Rallies As Psychedelic Drug Delivers Positive Anxiety Trial Results — Retail Says DT120 Could ‘Disrupt The Market’ Stocktwits",{"title":224,"link":225,"pubDate":226,"description":227,"source":193},"To cover vesting taxes, Definium Therapeutics (DFTX) CFO sells 3,377 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxPSGdQclVTaWs5aUQxbXhVZldDcEZWb1hHeTNTUjBiX3ZPWHdwVFVmc1hicE9YUFIwVzZQTE9Od256M2pmSV9xdHZHQ2F6cWhmcFVNUnp3eUV6Q1BFZFpUWDlfbXVlX2RfaktFVk4tYm43WlhZRmZIYzhFZlQ3OUdRM0pYaXQ1R3pXdGxEZkpadktQc2pGX0l0djhkUHVDT25seTFWeE9yWTBPbkZ6ZHF3M1hncm5tTUdsQ2U4?oc=5","Wed, 30 Sep 2026 01:21:08 GMT","To cover vesting taxes, Definium Therapeutics (DFTX) CFO sells 3,377 shares. Stock Titan",{"title":229,"link":230,"pubDate":231,"description":232,"source":181},"Will Positive Phase 3 Anxiety Data Change Definium Therapeutics' (DFTX) Narrative - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Will Positive Phase 3 Anxiety Data Change Definium Therapeutics' (DFTX) Narrative Simply Wall Street",{"title":234,"link":235,"pubDate":226,"description":236,"source":193},"To cover taxes on vested stock grants, Definium Therapeutics (DFTX) CEO sold 31,550 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxNM1p4VGRHcEZ2VW5GWmY4NXVfQVZ2N3VVOEhsVGJ1YTkxVTZQdHY3dkhWRS14bDJaX0EwdWZGZ3ZhSEJERkhSOTRvbjJMNXZfQlZaY0VmNkFYU1BrZkNtQ0VWZm4zaXZ5RWEweTBrVFNTTXJVT1pzZUJ3a0t5NkEwMTdNMTA5Z1dTRXFVdllDeng3dklmX3FGWkkxTU82WkJUek1Wa3hvT2p5a21Tb1ZldzNkRnk1azhFRzBj?oc=5","To cover taxes on vested stock grants, Definium Therapeutics (DFTX) CEO sold 31,550 shares. Stock Titan",{"title":238,"link":239,"pubDate":240,"description":241,"source":217},"Definium Therapeutics CEO Robert Barrow sells $1.15 million in shares - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxObm1LS1VmeUU2SF82UEppZm1wb2ZzdW1EVU5va3NxOFN0V0FVeDltdTlLNFowa2x6ZnBCN0Q2dUg1ZGZQYWlSMnBpd3ZpYXlLdE92d1ZzVTJvNU9PVTZYaW5ITjZLX1lPeE52Y0JqbkZhQWZoVlkybnVqcXJSaTdXdVZnRHRWSnNJUE1JVE92UUFac3llV3d3RzBpanVfRHctVzJ4Wi1ITEdtTzdqeDIzYU9PTTZQSmlSeHJ4Z1hreXRiSU9vUXJUSE5aNHU?oc=5","Wed, 30 Sep 2026 02:08:04 GMT","Definium Therapeutics CEO Robert Barrow sells $1.15 million in shares Investing.com",{"title":243,"link":244,"pubDate":245,"description":246,"source":193},"After selling 3,013 shares in June, a Definium Therapeutics (DFTX) officer proposes selling 3,377. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxPaGhlOW10dE9URlRua1p3czI0MjdWdTJ6Z2VVNlUwY3IzaDFVeW1kbi11TjQxSlZxYjNQZ2ppOWFZazNWdGc3UUEyWk1OMmp2R2hLTF8wU2VwV1FJd25wd1hQQXFjWmFfeThXc3R4UzRacDNzNzR5TmZ6bGNiYjhrYUJhNDZnVU9YS2NTRTFPdy0xVlp5VU5xaS1SaHo4TTlyV0lrUQ?oc=5","Fri, 25 Sep 2026 20:41:44 GMT","After selling 3,013 shares in June, a Definium Therapeutics (DFTX) officer proposes selling 3,377. Stock Titan",{"title":248,"link":249,"pubDate":250,"description":251,"source":193},"After selling 10,035 shares in June, a Definium Therapeutics (DFTX) officer proposes another sale. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxNeGZvMXdKMmI1d3BudVYyaEVWWUtPc2wyeW4tS29YeGFMY2IzZjJmZjNIbmhHM1hBTWJ2UlZVbGpuLVJ5UDVBSlI5LTNyVndIOVlLdTNvLWRiOGdJUjRNMUpSbGRTNEhvSkoteFk1TmNZV1N6Wk8xN2p2TVZLRnowVG56MVhlMGhYZ2RXam9iaGtQOHl2SHhIbWZfb19qWkdlYl92Qg?oc=5","Fri, 25 Sep 2026 20:17:31 GMT","After selling 10,035 shares in June, a Definium Therapeutics (DFTX) officer proposes another sale. Stock Titan",{"title":253,"link":254,"pubDate":255,"description":256,"source":193},"An officer sold 2,867 shares in the prior three months and lists 3,097 for sale at Definium Therapeutics (DFTX). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxPUzZweHBmMFE1bXdfdDR5N1Y5djZlaFctdXdzR3Q3YWpvbWJrU0hscGxOWlYzY25aRElObHVhdEtqWkJpbU15NjBYOHFOeFhBcnVKOUMyYXVhREUwcjZXRmc5aTlzcEdTb2hKUy1XeER1UnZDNjhSY18taG1hZUlOOEVyM1dyTklIYUVSS0owS19SSkREc1NoVS1wSEdaSEd0U0VlVQ?oc=5","Fri, 25 Sep 2026 20:41:45 GMT","An officer sold 2,867 shares in the prior three months and lists 3,097 for sale at Definium Therapeutics (DFTX). Stock Titan",{"title":258,"link":259,"pubDate":260,"description":261,"source":193},"After selling 13,008 shares in June, Definium Therapeutics (DFTX) officer Mark Sullivan proposes to sell 14,051. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxONHJrUUNIY0ZIenVVc3htQl9IVFBIQktHWV9TV3BaTVVOd0JpXzdzb2RFRVYyd2tvLTJ1STBqR0xsSmhKRDZGZUJfMXphWGVZMzlWekc2bmNnUE9yX19MMDRpa0tzMnJ6XzBRb2ZWaHI5WjNSX2JIQkJGWG1nS0hJQTRxS3hOQWI0eHAxX3h6UmFoVGtEOXBIdnBuNU1HcDE0YnZJbQ?oc=5","Fri, 25 Sep 2026 20:34:31 GMT","After selling 13,008 shares in June, Definium Therapeutics (DFTX) officer Mark Sullivan proposes to sell 14,051. Stock Titan",{"title":263,"link":264,"pubDate":231,"description":265,"source":266},"A Quick Look at Today's Ratings for Definium Therapeutics(DFTX.US), With a Forecast Between $66 to $91 - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxNZXUwUnVLcGw2b1E5WUtPU09lYXV2Qm95cHdCZzQ4Sk5xeFRKRDNTMHJtRDJSUllCQm5CZGJkb2RzWlJ6MW81OWVQYXRWb29lYjZ6VEFkTkhCaHJwR0NYOHdoblppTU9MaXFJa2FHZFEtalBwN3FvWnU4WDdUSFRwQUxsekxpeUNEbjJSX1MxTTd6WHVBV3VrYy16NVZjTnBS?oc=5","A Quick Look at Today's Ratings for Definium Therapeutics(DFTX.US), With a Forecast Between $66 to $91 Moomoo","Moomoo",{"title":268,"link":269,"pubDate":270,"description":271,"source":272},"Definium Therapeutics, Inc. (NASDAQ: DFTX) Stock Price, News & Analysis - kalkine.ca","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUEFVX3lxTE5mMGlkNVNFRHUtbGxWaVYtU1J6U0NIbU9QYV9EVkJySFJmQkxvUUtCUmhwdVpWQl9TN0lDZDUyaFF3N0hEcVYwZ0tQbWNIbFBl?oc=5","Fri, 02 Oct 2026 20:06:00 GMT","Definium Therapeutics, Inc. (NASDAQ: DFTX) Stock Price, News & Analysis kalkine.ca","kalkine.ca",{"title":274,"link":275,"pubDate":276,"description":277,"source":278},"DFTX261016C00042000 interactive stock chart | DFTX Oct 2026 42.000 call stock - uk.finance.yahoo.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZEFVX3lxTFBEbVl5TUlzZjA0aHBhdTVnNzB5TUhmWU5FaHRuUGprbGl5UU9WaHFrbUZBblU1V0hZTV9QMGNya3g3bHludFQ5VE1QVERpOUV2NmRMOHlVLVctYm1meC1vNzg2cU0?oc=5","Wed, 30 Sep 2026 14:08:37 GMT","DFTX261016C00042000 interactive stock chart | DFTX Oct 2026 42.000 call stock uk.finance.yahoo.com","uk.finance.yahoo.com",{"title":280,"link":281,"pubDate":282,"description":283,"source":217},"Definium Therapeutics CLO Mark Sullivan sells $513,845 in shares - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxPaV9QRW5xakQzSmFVSzNyNG5RYktybHNkQzVWMmlBLWgwalRPRjJ0VkxZemRheE4zVXdiajM0YWh2MF9XTUVCSTgzdmxoX0ZVZnV6Z3JxMUJyTTVUNHE2OG9qeDhhMGdsNThnR3dkY0RLLVVieHB2SEFndVI0RWMyenR3dWp6enQ4SnFRWGtZdS1sQmVZTlJnczlpYWZud1Fpc2NtZWE1VGNVTElHam5OUGZ6OWRPQUFpNFE3TkdTSnBlNFlHM3c?oc=5","Wed, 30 Sep 2026 01:43:08 GMT","Definium Therapeutics CLO Mark Sullivan sells $513,845 in shares Investing.com"]